吡拉西坦、依达拉奉及长春西汀联合治疗出血性脑梗死的效果及安全性研究

  • 打印
  • 收藏
收藏成功


打开文本图片集

中图分类号:R743.33 文献标识码:A文章编号:1006-1959(2026)05-0140-04

DOI:10.3969/j.issn.1006-1959.2026.05.025

Studyon theEfficacyand Safety ofPiracetam,Edaravoneand Vinpocetine intheTreatmentofHemorrhagicCerebralInfarction

ZHANG Yanghui

(DepartmentofNeurology,TianjinPKUCareCNOOCHospital,Tianjin3OO452,China)

Abstract:Oetialthcdetyaceaadpoiieatical MethodsFromJuneO21toMay224,8OpatientswithhemorrhagiccerebralinfarctionadmitedtoTianjinPKUCareCNOOCHospitalwere selectedasteeseachectsUsingtadumbetableeodeyeresidtosudoupndotrolgoupittsin eachgroup.TheotroloupeedobidmdicatiowithiaceaddaravohilethesudyoupasivenditioaloetiA comparisoaadeoosinfalactioalstutaltroealeSl hematomavolendteidencfdeseeactiorowissresdpetitbdalpinndasedig). ResultsToeosaediatlgeotalfteofetoiodall hematomavolusfeetoaredtooolop).osiantdiferecesotedeteousisfde reaction rates( P >0.05).CnclusionThecombinationofpiracetam,edaravone,andvinpocetinesignificantlyimprovesneurologicalfunctioand reduces cerebral hematomavolumeinpatientswith hemorrhagiccerebral infarction,withafavorablesafetyprofile.

KeyWords:Piracetam;Edaravone;Vinpocetine;Hemorrhagiccerebral infarction

脑梗死后继发出血现象,通常称作出血性脑卒中,是指脑部血管在梗死后重新获得血液供应,却导致了梗死区域的出血性并发症。(剩余5373字)

目录
monitor
客服机器人